Ridgeback Biotherapeutics LP announces receipt of Breakthrough Therapy designation from FDA for mAb114 Read more
Schrödinger Announces Collaboration with AstraZeneca to Deploy Advanced Computing Technology for Drug Discovery Read more
ZyVersa Therapeutics to Advance Development of Its Lead Inflammasome Inhibitor with Selexis and KBI Biopharma’s Integrated Development Platform Read more